Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423195 | 0.88 | HRH3 (0.42) | ABCB11LMNAMAPTMAPK1KDM4E | |
| SCHEMBL7438468 | 0.86 | MAPT (0.50) | ABCB11LMNAMAPTMAPK1KMT2A | |
| SCHEMBL7430505 | 0.86 | MAPK1 (0.44) | ABCB11LMNAMAPTMAPK1KMT2A | |
| SCHEMBL7481816 | 0.86 | LMNA (0.51) | ABCB11LMNAMAPTMAPK1KDM4E | |
| SCHEMBL6262433 | 0.85 | MAPT (0.68) | ABCB11LMNAMAPTMAPK1HRH3 | |
| SCHEMBL6262992 | 0.85 | MAPT (0.68) | ABCB11LMNAMAPTMAPK1HRH3 | |
| SCHEMBL6263163 | 0.85 | MAPT (0.52) | ABCB11LMNAMAPTMAPK1KMT2A | |
| SCHEMBL7426444 | 0.85 | MAPT (0.52) | ABCB11LMNAMAPTMAPK1KMT2A | |
| SCHEMBL6260245 | 0.85 | LMNA (0.53) | ABCB11LMNAMAPTMAPK1KDM4E | |
| SCHEMBL7433424 | 0.85 | LMNA (0.53) | ABCB11LMNAMAPTMAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1275390-B1 | Medicament for treatment of heart failure | WOLF HORST P O (DE) | 2005-11-02 | — | — | EP | claimed |
| EP-1275390-A2 | Medicament for treatment of heart failure | MediGene AG Gesellschaft für Molekularbiologische Kardiologie und Onkologie (DE) | 2003-01-15 | — | — | EP | claimed |
| EP-0731700-A1 | MEDICAMENT FOR TREATING HEART INSUFFICIENCY | Wolf, Horst P.O., Dr. (DE) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015161-A2 | MEDICAMENT FOR TREATING HEART INSUFFICIENCY | WOLF HORST P O (DE) | 1995-06-08 | — | — | WO | claimed |
| EP-0231367-B1 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA | Wolf, Horst P.O., Dr. (DE) | 1991-07-24 | — | — | EP | claimed |
| US-4946866-A | REDUCTION OF CHOLESTEROL OR TRIGLYCERIDE CONCENTRATION; TREATMENT OF ARTERIOSCLEROSIS AND CARDIOVASCULAR DISORDERS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1990-08-07 | — | — | US | claimed |
| EP-0231367-A1 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA. | BYK GULDEN LOMBERG CHEM FAB (DE) | 1987-08-12 | — | — | EP | claimed |
| WO-1987000751-A2 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1987-02-12 | — | — | WO | claimed |
| EP-0046590-B1 | PHEN(ALK)OXY-SUBSTITUTED OXIRANE-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR USE AND DRUGS CONTAINING THEM | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1985-05-22 | — | — | EP | claimed |
| EP-1275390-B1 | Medicament for treatment of heart failure | WOLF HORST P O (DE) | 2005-11-02 | — | — | EP | disclosed |
| EP-1275390-A2 | Medicament for treatment of heart failure | MediGene AG Gesellschaft für Molekularbiologische Kardiologie und Onkologie (DE) | 2003-01-15 | — | — | EP | disclosed |
| EP-0731700-A1 | MEDICAMENT FOR TREATING HEART INSUFFICIENCY | Wolf, Horst P.O., Dr. (DE) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015161-A2 | MEDICAMENT FOR TREATING HEART INSUFFICIENCY | WOLF HORST P O (DE) | 1995-06-08 | — | — | WO | disclosed |
| EP-0231367-B1 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA | Wolf, Horst P.O., Dr. (DE) | 1991-07-24 | — | — | EP | disclosed |
| EP-0231367-A1 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA. | BYK GULDEN LOMBERG CHEM FAB (DE) | 1987-08-12 | — | — | EP | disclosed |
| WO-1987000751-A2 | USE OF OXIRANCARBOXYLIC ACIDS FOR THE TREATMENT OF HYPERLIPEMIA | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1987-02-12 | — | — | WO | disclosed |
| EP-0046590-B1 | PHEN(ALK)OXY-SUBSTITUTED OXIRANE-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR USE AND DRUGS CONTAINING THEM | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1985-05-22 | — | — | EP | disclosed |
| WO-1982000643-A1 | SUBSTITUTED OXIRANECARBONIC ACIDS,PREPARATION AND PHARMACEUTICAL UTILISATION THEREOF | BYK GULDEN LOMBERG CHEM FAB (DE) | 1982-03-04 | — | — | WO | disclosed |
| EP-0046590-A2 | Phen(alk)oxy-substituted oxirane-carboxylic acids, process for their preparation, their use and drugs containing them | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1982-03-03 | — | — | EP | disclosed |